The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended five novel medicines for approval at its ...

The US Food and Drug Administration (FDA) on Friday announced it has approved two new oral medicines to treat a common ...

British pharma major AstraZeneca (LSE: AZN) has joined a near-$100 million series A and A+ financing round for Syneron Bio, a ...

Danish biotech Sidera Bio has raised about 700 million Kroner ($109 million) in a series A financing, one of the largest ...

New York, USA-based rare disease firm Applied Therapeutics has announced a definitive agreement to be acquired by privately-held UK-based Cycle Pharmaceuticals.

A major European pharmacy meeting that combines a professional congress with a large exhibition focused on medicines and ...

The US Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for the use of an oral pellet ...

Medra, a US company developing the first platform for physical AI scientists, has announced a $52 million Series A financing.

US late-stage rare disease focused pharma Rezolute announced disappointing top-line results from its Phase III sunRIZE study ...

Eli Lilly has shown the strength of its obesity pipeline beyond its on-market blockbuster Mounjaro (tirzepatide) ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ezmekly (mirdametinib) for the treatment of ...